Showing results (261-270 of 537) with videos related to
Sort By:
Pageof 54
Cephalalgia : an International Journal of Headache|February 15, 2022
FollowTheSutures: Piloting a new way to administer onabotulinumtoxinA for chronic migraineLars Jacob Stovner, Knut Hagen, Erling Tronvik, et al.Journal of Neurosurgical Anesthesiology|October 10, 2009
Occipital nerve stimulator placement under general anesthesia: initial experience with 5 cases and review of the literatureTerrence L Trentman, Richard S Zimmerman, David W Dodick, et al.Vaccine|June 4, 2025
RSV vaccines and Guillain-Barré syndrome: Insights into an emerging concernCleo Anastassopoulou, Antonios-Periklis Panagiotopoulos, Stefanos Ferous, et al.Headache|May 23, 2024
Functional impairment of chronic migraine with medication overuse: Secondary analysis from the Medication Overuse Treatment Strategy (MOTS) trialSamantha C Shao, Joseph Hentz, Patti Shank, et al.Headache|October 31, 2018
Health care Resource Utilization and Migraine Disability Along the Migraine Continuum Among Patients Treated for MigraineStephen D Silberstein, Lulu Lee, Kavita Gandhi, et al.Headache|April 19, 2006
Acetaminophen, aspirin, and caffeine in combination versus ibuprofen for acute migraine: results from a multicenter, double-blind, randomized, parallel-group, single-dose, placebo-controlled studyJerome Goldstein, Stephen D Silberstein, Joel R Saper, et al.Headache|October 3, 2021
Intravenous ibuprofen for acute treatment of migraine: A double-blind, randomized, placebo-controlled pilot studyHsiangkuo Yuan, John G Curran, Scott W Keith, et al.Headache|June 27, 2024
Clinical factors associated with day-to-day peak pain severity in individuals with chronic migraine: A cohort study using daily prospective diary dataMarina Vives-Mestres, Amparo Casanova, Stephen D Silberstein, et al.Journal of Occupational and Environmental Medicine|March 14, 2007
Impact of topiramate migraine prophylaxis on workplace productivity: results from two US randomized, double-blind, placebo-controlled, multicenter trialsJennifer H Lofland, Joshua J Gagne, Laura T Pizzi, et al.ACS Chemical Neuroscience|August 21, 2014
Targeting TRP channels for novel migraine therapeuticsGregory Dussor, J Yan, Jennifer Y Xie, et al.Pageof 54